<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:50:22 -0700</creation_date>
  <update_date>2013-05-27 11:40:21 -0600</update_date>
  <accession>HMDBP00480</accession>
  <secondary_accessions>
    <accession>5721</accession>
    <accession>HMDBP04818</accession>
  </secondary_accessions>
  <protein_type>Enzyme</protein_type>
  <synonyms>
    <synonym>3,4-catechol estrogen-specific UDPGT</synonym>
    <synonym>UDP-glucuronosyltransferase 2B9</synonym>
    <synonym>UDPGT 2B7</synonym>
    <synonym>UDPGT 2B9</synonym>
    <synonym>UDPGTh-2</synonym>
  </synonyms>
  <gene_name>UGT2B7</gene_name>
  <general_function>Involved in transferase activity, transferring hexosyl groups</general_function>
  <specific_function>UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds.
Its unique specificity for 3,4-catechol estrogens and estriol suggests it may play an important role in regulating the level and activity of these potent and active estrogen metabolites. Is also active with androsterone, hyodeoxycholic acid and tetrachlorocatechol (in vitro).
</specific_function>
  <pathways>
    <pathway>
      <name>Pentose and glucuronate interconversions</name>
      <smpdb_id/>
      <kegg_map_id>map00040</kegg_map_id>
    </pathway>
    <pathway>
      <name>Ascorbate and aldarate metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00053</kegg_map_id>
    </pathway>
    <pathway>
      <name>Steroid hormone biosynthesis</name>
      <smpdb_id/>
      <kegg_map_id>map00140</kegg_map_id>
    </pathway>
    <pathway>
      <name>Starch and sucrose metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00500</kegg_map_id>
    </pathway>
    <pathway>
      <name>Retinol metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00830</kegg_map_id>
    </pathway>
    <pathway>
      <name>Porphyrin and chlorophyll metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00860</kegg_map_id>
    </pathway>
    <pathway>
      <name>Metabolism of xenobiotics by cytochrome P450</name>
      <smpdb_id/>
      <kegg_map_id>map00980</kegg_map_id>
    </pathway>
    <pathway>
      <name>Drug metabolism - cytochrome P450</name>
      <smpdb_id/>
      <kegg_map_id>map00982</kegg_map_id>
    </pathway>
    <pathway>
      <name>Drug metabolism - other enzymes</name>
      <smpdb_id/>
      <kegg_map_id>map00983</kegg_map_id>
    </pathway>
    <pathway>
      <name>Chemical carcinogenesis</name>
      <smpdb_id/>
      <kegg_map_id>map05204</kegg_map_id>
    </pathway>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB00901</accession>
      <name>Valproic acid glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01272</accession>
      <name>Nicotine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02829</accession>
      <name>Androsterone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03141</accession>
      <name>Retinoyl b-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03193</accession>
      <name>Testosterone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04482</accession>
      <name>2-Methoxyestrone 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04483</accession>
      <name>Estrone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06203</accession>
      <name>5-alpha-Dihydrotestosterone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06224</accession>
      <name>17-beta-Estradiol-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10315</accession>
      <name>4-Hydroxyandrostenedione glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10317</accession>
      <name>17-beta-Estradiol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10318</accession>
      <name>Pregnanediol-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10321</accession>
      <name>3,17-Androstanediol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10322</accession>
      <name>17-alpha-Estradiol-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10325</accession>
      <name>Ethyl glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10327</accession>
      <name>Dehydroisoandrosterone 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10334</accession>
      <name>Ketoprofen glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10335</accession>
      <name>Estriol-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10337</accession>
      <name>6-Dehydrotestosterone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10338</accession>
      <name>11-Oxo-androsterone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10339</accession>
      <name>3-alpha-Androstanediol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10340</accession>
      <name>Retinyl beta-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10343</accession>
      <name>1-(alpha-Methyl-4-(2-methylpropyl)benzeneacetate)-beta-D-Glucopyranuronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10345</accession>
      <name>Aldosterone 18-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10348</accession>
      <name>Dehydroepiandrosterone 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10349</accession>
      <name>Estradiol-17alpha 3-D-glucuronoside</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10351</accession>
      <name>11-beta-Hydroxyandrosterone-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10353</accession>
      <name>15-Hydroxynorandrostene-3,17-dione glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10354</accession>
      <name>16-alpha,17-beta-estriol 17-beta-D-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10356</accession>
      <name>Estriol 3-sulfate 16-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10357</accession>
      <name>Tetrahydroaldosterone-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10359</accession>
      <name>17-Hydroxyandrostane-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10364</accession>
      <name>11-Hydroxyprogesterone 11-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10365</accession>
      <name>3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00031</accession>
      <name>Androsterone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01390</accession>
      <name>Hydroxycotinine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00010</accession>
      <name>2-Methoxyestrone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00054</accession>
      <name>Bilirubin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00145</accession>
      <name>Estrone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00151</accession>
      <name>Estradiol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00153</accession>
      <name>Estriol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00234</accession>
      <name>Testosterone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00295</accession>
      <name>Uridine 5'-diphosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00405</accession>
      <name>2-Methoxyestradiol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00490</accession>
      <name>Etiocholanolone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00496</accession>
      <name>3-Methoxy-4-hydroxyphenylglycol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00935</accession>
      <name>Uridine diphosphate glucuronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01013</accession>
      <name>Cotinine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01204</accession>
      <name>trans-3-Hydroxycotinine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01852</accession>
      <name>All-trans-retinoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02091</accession>
      <name>Isovalerylglucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02513</accession>
      <name>Lithocholate 3-O-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02577</accession>
      <name>Cholic acid glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02579</accession>
      <name>Glycochenodeoxycholic acid 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02596</accession>
      <name>Deoxycholic acid 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02833</accession>
      <name>Testosterone sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03325</accession>
      <name>Bilirubin diglucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04484</accession>
      <name>Etiocholanolone glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04995</accession>
      <name>Codeine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06765</accession>
      <name>2-Methoxy-estradiol-17b 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06766</accession>
      <name>Estriol-16-Glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10313</accession>
      <name>1-Salicylate glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10319</accession>
      <name>Inodxyl glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10320</accession>
      <name>Cortolone-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10323</accession>
      <name>Phenethylamine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10324</accession>
      <name>Benzoyl glucuronide (Benzoic acid)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10326</accession>
      <name>Thyroxine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10328</accession>
      <name>Tyramine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10329</accession>
      <name>Dopamine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10330</accession>
      <name>Cholesterol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10331</accession>
      <name>Palmitoyl glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10332</accession>
      <name>Bilirubin glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10333</accession>
      <name>Estriol-17-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10336</accession>
      <name>Epinephrine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10341</accession>
      <name>Dextrorphan O-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10342</accession>
      <name>25-Hydroxyvitamin D2-25-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10344</accession>
      <name>Vitamin D2 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10346</accession>
      <name>Triiodothyronine glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10347</accession>
      <name>Octanoylglucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10350</accession>
      <name>2-Phenylethanol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10352</accession>
      <name>3-alpha,20-alpha-Dihydroxy-5-beta-pregnane 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10355</accession>
      <name>Cholestane-3,7,12,25-tetrol-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10360</accession>
      <name>25-Hydroxyvitamin D2 25-(beta-glucuronide)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10361</accession>
      <name>(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10362</accession>
      <name>6-Hydroxy-5-methoxyindole glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10363</accession>
      <name>5-Hydroxy-6-methoxyindole glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14440</accession>
      <name>Morphine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14588</accession>
      <name>Epirubicin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13974</accession>
      <name>4'-Hydroxydiclofenac</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13846</accession>
      <name>E-3179</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14826</accession>
      <name>Mycophenolate mofetil</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14850</accession>
      <name>Flurbiprofen</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13989</accession>
      <name>O-Desmethylnaproxen</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15008</accession>
      <name>Suprofen</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15108</accession>
      <name>Ezetimibe</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15159</accession>
      <name>Mycophenolic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15382</accession>
      <name>Mitiglinide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15510</accession>
      <name>Flunitrazepam</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00127</accession>
      <name>D-Glucuronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00580</accession>
      <name>Chondroitin sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00639</accession>
      <name>Galactaric acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00652</accession>
      <name>Chondroitin 4-sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00663</accession>
      <name>Glucaric acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00693</accession>
      <name>Heparan sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01394</accession>
      <name>Heparin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02061</accession>
      <name>Hyaluronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02429</accession>
      <name>(3a,5b)-24-oxo-24-[(2-sulfoethyl)amino]cholan-3-yl-b-D-Glucopyranosiduronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02430</accession>
      <name>(3a,5b,7a)-23-Carboxy-7-hydroxy-24-norcholan-3-yl-b-D-Glucopyranosiduronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02472</accession>
      <name>(3a,5b,7a,12a)-24-[(carboxymethyl)amino]-1,12-dihydroxy-24-oxocholan-3-yl-b-D-Glucopyranosiduronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02545</accession>
      <name>Galacturonic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02704</accession>
      <name>Iduronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03363</accession>
      <name>Pectic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03402</accession>
      <name>Pectin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03976</accession>
      <name>D-Glucuronic acid 1-phosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10316</accession>
      <name>Acetaminophen glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10358</accession>
      <name>17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10366</accession>
      <name>Hyaluronan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11658</accession>
      <name>2,8-Dihydroxyquinoline-beta-D-glucuronide </name>
    </metabolite>
    <metabolite>
      <accession>HMDB11686</accession>
      <name>p-Cresol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12302</accession>
      <name>UDP-D-galacturonate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12304</accession>
      <name>UDP-L-iduronate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13847</accession>
      <name>Losartan N2-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14551</accession>
      <name>Ardeparin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14709</accession>
      <name>Fondaparinux sodium</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15356</accession>
      <name>Enoxaparin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29212</accession>
      <name>Quercetin 3-O-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29214</accession>
      <name>Quercetin-4'-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29357</accession>
      <name>Betavulgaroside I</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29406</accession>
      <name>Amaranthin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29500</accession>
      <name>Kaempferol 3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29844</accession>
      <name>Glyciram</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29881</accession>
      <name>D-Glucaric acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29917</accession>
      <name>2-O-(4-O-Methyl-a-D-glucopyranuronosyl)-D-xylose</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29923</accession>
      <name>Xanthan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29938</accession>
      <name>Acaciabiuronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB29940</accession>
      <name>Alginic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB30498</accession>
      <name>Camelliasaponin A1</name>
    </metabolite>
    <metabolite>
      <accession>HMDB30499</accession>
      <name>Camelliasaponin A2</name>
    </metabolite>
    <metabolite>
      <accession>HMDB30976</accession>
      <name>Durupcoside B</name>
    </metabolite>
    <metabolite>
      <accession>HMDB30977</accession>
      <name>Durupcoside A</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31022</accession>
      <name>Elatoside I</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31023</accession>
      <name>Achyranthoside D</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31024</accession>
      <name>Achyranthoside C</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31025</accession>
      <name>Betavulgaroside IV</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31026</accession>
      <name>Calenduloside H</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31027</accession>
      <name>Tuberoside B (Ullucus tuberosus)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31353</accession>
      <name>Kudzusaponin SA4</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31656</accession>
      <name>Jaceidin 4'-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31883</accession>
      <name>Sandosaponin B</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31884</accession>
      <name>Sandosaponin A</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31959</accession>
      <name>Lablaboside D</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31960</accession>
      <name>Lablaboside E</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31961</accession>
      <name>Lablaboside F</name>
    </metabolite>
    <metabolite>
      <accession>HMDB31965</accession>
      <name>Melilotussaponin O1</name>
    </metabolite>
    <metabolite>
      <accession>HMDB33105</accession>
      <name>N2-Galacturonyl-L-lysine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB33106</accession>
      <name>N6-Galacturonyl-L-lysine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB34379</accession>
      <name>Silenoside A</name>
    </metabolite>
    <metabolite>
      <accession>HMDB34389</accession>
      <name>Silenoside B</name>
    </metabolite>
    <metabolite>
      <accession>HMDB34390</accession>
      <name>Silenoside C</name>
    </metabolite>
    <metabolite>
      <accession>HMDB41796</accession>
      <name>2,2,2-Trichloroethanol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB42049</accession>
      <name>Trichloroethanol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB60510</accession>
      <name>SN-38</name>
    </metabolite>
    <metabolite>
      <accession>HMDB60511</accession>
      <name>SN38 glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB60464</accession>
      <name>Codeine-6-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB41936</accession>
      <name>Morphine-3-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB41937</accession>
      <name>Morphine-6-glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02111</accession>
      <name>Water</name>
    </metabolite>
    <metabolite>
      <accession>HMDB41809</accession>
      <name>4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB60383</accession>
      <name>4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB60498</accession>
      <name>NNAL-N-glucuronide</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>catalytic activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>transferase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>transferase activity, transferring glycosyl groups</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>transferase activity, transferring hexosyl groups</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>endoplasmic reticulum membrane</description>
      <go_id>GO:0005789</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>integral to membrane</description>
      <go_id>GO:0016021</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>membrane</description>
      <go_id>GO:0016020</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>glucuronosyltransferase activity</description>
      <go_id>GO:0015020</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>androgen metabolic process</description>
      <go_id>GO:0008209</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular glucuronidation</description>
      <go_id>GO:0052695</go_id>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Microsome membrane</subcellular_location>
    <subcellular_location>Single-pass membrane protein (Potential)</subcellular_location>
    <subcellular_location>Endoplasmic reticulum membrane</subcellular_location>
    <subcellular_location>Single-pass membrane protein (Potential)</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>4</chromosome_location>
    <locus>4q13</locus>
    <gene_sequence>&gt;1590 bp
ATGTCTGTGAAATGGACTTCAGTAATTTTGCTAATACAACTGAGCTTTTGCTTTAGCTCT
GGGAATTGTGGAAAGGTGCTGGTGTGGGCAGCAGAATACAGCCATTGGATGAATATAAAG
ACAATCCTGGATGAGCTTATTCAGAGAGGTCATGAGGTGACTGTACTGGCATCTTCAGCT
TCCATTCTTTTTGATCCCAACAACTCATCCGCTCTTAAAATTGAAATTTATCCCACATCT
TTAACTAAAACTGAGTTGGAGAATTTCATCATGCAACAGATTAAGAGATGGTCAGACCTT
CCAAAAGATACATTTTGGTTATATTTTTCACAAGTACAGGAAATCATGTCAATATTTGGT
GACATAACTAGAAAGTTCTGTAAAGATGTAGTTTCAAATAAGAAATTTATGAAAAAAGTA
CAAGAGTCAAGATTTGACGTCATTTTTGCAGATGCTATTTTTCCCTGTAGTGAGCTGCTG
GCTGAGCTATTTAACATACCCTTTGTGTACAGTCTCAGCTTCTCTCCTGGCTACACTTTT
GAAAAGCATAGTGGAGGATTTATTTTCCCTCCTTCCTACGTACCTGTTGTTATGTCAGAA
TTAACTGATCAAATGACTTTCATGGAGAGGGTAAAAAATATGATCTATGTGCTTTACTTT
GACTTTTGGTTCGAAATATTTGACATGAAGAAGTGGGATCAGTTTTATAGTGAAGTTCTA
GGAAGACCCACTACGTTATCTGAGACAATGGGGAAAGCTGACGTATGGCTTATTCGAAAC
TCCTGGAATTTTCAGTTTCCTCATCCACTCTTACCAAATGTTGATTTTGTTGGAGGACTC
CACTGCAAACCTGCCAAACCCCTGCCTAAGGAAATGGAAGACTTTGTACAGAGCTCTGGA
GAAAATGGTGTTGTGGTGTTTTCTCTGGGGTCAATGGTCAGTAACATGACAGAAGAAAGG
GCCAACGTAATTGCATCAGCCCTGGCCCAGATCCCACAAAAGGTTCTGTGGAGATTTGAT
GGGAATAAACCAGATACCTTAGGTCTCAATACTCGGCTGTATAAGTGGATACCCCAGAAT
GACCTTCTAGGTCATCCAAAGACCAGAGCTTTTATAACTCATGGTGGAGCCAATGGCATC
TACGAGGCAATCTACCATGGGATCCCTATGGTGGGGATTCCATTGTTTGCCGATCAACCT
GATAACATTGCTCACATGAAGGCCAGGGGAGCAGCTGTTAGAGTGGACTTCAACACAATG
TCGAGTACAGACTTGCTGAATGCATTGAAGAGAGTAATTAATGATCCTTCATATAAAGAG
AATGTTATGAAATTATCAAGAATTCAACATGATCAACCAGTGAAGCCCCTGGATCGAGCA
GTCTTCTGGATTGAATTTGTCATGCGCCACAAAGGAGCTAAACACCTTCGGGTTGCAGCC
CACGACCTCACCTGGTTCCAGTACCACTCTTTGGATGTGATTGGGTTCCTGCTGGTCTGT
GTGGCAACTGTGATATTTATCGTCACAAAATGTTGTCTGTTTTGTTTCTGGAAGTTTGCT
AGAAAAGCAAAGAAGGGAAAAAATGATTAG</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>529</residue_number>
    <molecular_weight>60720.15</molecular_weight>
    <theoretical_pi>8.303</theoretical_pi>
    <pfams>
      <pfam>
        <name>UDPGT</name>
        <pfam_id>PF00201</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
    </signal_regions>
    <protein_sequence>&gt;UDP-glucuronosyltransferase 2B7
MSVKWTSVILLIQLSFCFSSGNCGKVLVWAAEYSHWMNIKTILDELIQRGHEVTVLASSA
SILFDPNNSSALKIEIYPTSLTKTELENFIMQQIKRWSDLPKDTFWLYFSQVQEIMSIFG
DITRKFCKDVVSNKKFMKKVQESRFDVIFADAIFPCSELLAELFNIPFVYSLSFSPGYTF
EKHSGGFIFPPSYVPVVMSELTDQMTFMERVKNMIYVLYFDFWFEIFDMKKWDQFYSEVL
GRPTTLSETMGKADVWLIRNSWNFQFPHPLLPNVDFVGGLHCKPAKPLPKEMEDFVQSSG
ENGVVVFSLGSMVSNMTEERANVIASALAQIPQKVLWRFDGNKPDTLGLNTRLYKWIPQN
DLLGHPKTRAFITHGGANGIYEAIYHGIPMVGIPLFADQPDNIAHMKARGAAVRVDFNTM
SSTDLLNALKRVINDPSYKENVMKLSRIQHDQPVKPLDRAVFWIEFVMRHKGAKHLRVAA
HDLTWFQYHSLDVIGFLLVCVATVIFIVTKCCLFCFWKFARKAKKGKND</protein_sequence>
  </protein_properties>
  <genbank_protein_id/>
  <uniprot_id>P16662</uniprot_id>
  <uniprot_name>UD2B7_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>2O6L</pdb_id>
  </pdb_ids>
  <genbank_gene_id>J05428</genbank_gene_id>
  <genecard_id>UGT2B7</genecard_id>
  <geneatlas_id>UGT2B7</geneatlas_id>
  <hgnc_id>HGNC:12554</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Ritter JK, Sheen YY, Owens IS: Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells. 3,4-catechol estrogens and estriol as primary substrates. J Biol Chem. 1990 May 15;265(14):7900-6.</reference_text>
      <pubmed_id>2159463</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.</reference_text>
      <pubmed_id>14702039</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31.</reference_text>
      <pubmed_id>15815621</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.</reference_text>
      <pubmed_id>15489334</pubmed_id>
    </reference>
    <reference>
      <reference_text>Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61.</reference_text>
      <pubmed_id>19159218</pubmed_id>
    </reference>
    <reference>
      <reference_text>Bhasker CR, McKinnon W, Stone A, Lo AC, Kubota T, Ishizaki T, Miners JO: Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. Pharmacogenetics. 2000 Nov;10(8):679-85.</reference_text>
      <pubmed_id>11186130</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
    <metabolite_reference>
      <metabolite>
        <name>Valproic acid glucuronide</name>
        <accession>HMDB00901</accession>
      </metabolite>
      <reference>
        <reference_text>Ethell BT, Anderson GD, Burchell B: The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases. Biochem Pharmacol. 2003 May 1;65(9):1441-9.</reference_text>
        <pubmed_id>12732356</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Nicotine glucuronide</name>
        <accession>HMDB01272</accession>
      </metabolite>
      <reference>
        <reference_text>Kaivosaari S, Toivonen P, Hesse LM, Koskinen M, Court MH, Finel M: Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10. Mol Pharmacol. 2007 Sep;72(3):761-8. Epub 2007 Jun 18.</reference_text>
        <pubmed_id>17576790</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Retinoyl b-glucuronide</name>
        <accession>HMDB03141</accession>
      </metabolite>
      <reference>
        <reference_text>Gestl SA, Green MD, Shearer DA, Frauenhoffer E, Tephly TR, Weisz J: Expression of UGT2B7, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers. Am J Pathol. 2002 Apr;160(4):1467-79.</reference_text>
        <pubmed_id>11943730</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ethyl glucuronide</name>
        <accession>HMDB10325</accession>
      </metabolite>
      <reference>
        <reference_text>Foti RS, Fisher MB: Assessment of UDP-glucuronosyltransferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs. Forensic Sci Int. 2005 Oct 29;153(2-3):109-16. Epub 2005 Jan 15.</reference_text>
        <pubmed_id>16139098</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ketoprofen glucuronide</name>
        <accession>HMDB10334</accession>
      </metabolite>
      <reference>
        <reference_text>Kuehl GE, Lampe JW, Potter JD, Bigler J: Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes. Drug Metab Dispos. 2005 Jul;33(7):1027-35. Epub 2005 Apr 20.</reference_text>
        <pubmed_id>15843492</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Retinyl beta-glucuronide</name>
        <accession>HMDB10340</accession>
      </metabolite>
      <reference>
        <reference_text>Genchi G, Wang W, Barua A, Bidlack WR, Olson JA: Formation of beta-glucuronides and of beta-galacturonides of various retinoids catalyzed by induced and noninduced microsomal UDP-glucuronosyltransferases of rat liver. Biochim Biophys Acta. 1996 Mar 15;1289(2):284-90.</reference_text>
        <pubmed_id>8600986</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>1-(alpha-Methyl-4-(2-methylpropyl)benzeneacetate)-beta-D-Glucopyranuronic acid</name>
        <accession>HMDB10343</accession>
      </metabolite>
      <reference>
        <reference_text>Kuehl GE, Lampe JW, Potter JD, Bigler J: Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes. Drug Metab Dispos. 2005 Jul;33(7):1027-35. Epub 2005 Apr 20.</reference_text>
        <pubmed_id>15843492</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Aldosterone 18-glucuronide</name>
        <accession>HMDB10345</accession>
      </metabolite>
      <reference>
        <reference_text>Girard C, Barbier O, Veilleux G, El-Alfy M, Belanger A: Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites. Endocrinology. 2003 Jun;144(6):2659-68.</reference_text>
        <pubmed_id>12746330</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Tetrahydroaldosterone-3-glucuronide</name>
        <accession>HMDB10357</accession>
      </metabolite>
      <reference>
        <reference_text>Girard C, Barbier O, Veilleux G, El-Alfy M, Belanger A: Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites. Endocrinology. 2003 Jun;144(6):2659-68.</reference_text>
        <pubmed_id>12746330</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Androsterone</name>
        <accession>HMDB00031</accession>
      </metabolite>
      <reference>
        <reference_text>Coffman BL, King CD, Rios GR, Tephly TR: The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab Dispos. 1998 Jan;26(1):73-7.</reference_text>
        <pubmed_id>9443856</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Hydroxycotinine</name>
        <accession>HMDB01390</accession>
      </metabolite>
      <reference>
        <reference_text>Yamanaka H, Nakajima M, Katoh M, Kanoh A, Tamura O, Ishibashi H, Yokoi T: Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes. Drug Metab Dispos. 2005 Jan;33(1):23-30. Epub 2004 Oct 6.</reference_text>
        <pubmed_id>15470160</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Morphine</name>
        <accession>HMDB14440</accession>
      </metabolite>
      <reference>
        <reference_text>Coffman BL, Rios GR, King CD, Tephly TR: Human UGT2B7 catalyzes morphine glucuronidation.  Drug Metab Dispos. 1997 Jan;25(1):1-4.</reference_text>
        <pubmed_id>9010622</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Morphine</name>
        <accession>HMDB14440</accession>
      </metabolite>
      <reference>
        <reference_text>Takeda S, Ishii Y, Iwanaga M, Mackenzie PI, Nagata K, Yamazoe Y, Oguri K, Yamada H: Modulation of UDP-glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4. Mol Pharmacol. 2005 Mar;67(3):665-72. Epub 2004 Dec 20.</reference_text>
        <pubmed_id>15611481</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Morphine</name>
        <accession>HMDB14440</accession>
      </metabolite>
      <reference>
        <reference_text>Yamada H, Ishii K, Ishii Y, Ieiri I, Nishio S, Morioka T, Oguri K: Formation of highly analgesic morphine-6-glucuronide following physiologic concentration of morphine in human brain. J Toxicol Sci. 2003 Dec;28(5):395-401.</reference_text>
        <pubmed_id>14746343</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Morphine</name>
        <accession>HMDB14440</accession>
      </metabolite>
      <reference>
        <reference_text>Abildskov K, Weldy P, Garland M: Molecular cloning of the baboon UDP-glucuronosyltransferase 2B gene family and their activity in conjugating morphine. Drug Metab Dispos. 2010 Apr;38(4):545-53. Epub 2010 Jan 13.</reference_text>
        <pubmed_id>20071451</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Epirubicin</name>
        <accession>HMDB14588</accession>
      </metabolite>
      <reference>
        <reference_text>Innocenti F, Iyer L, Ramirez J, Green MD, Ratain MJ: Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. Drug Metab Dispos. 2001 May;29(5):686-92.</reference_text>
        <pubmed_id>11302935</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Epirubicin</name>
        <accession>HMDB14588</accession>
      </metabolite>
      <reference>
        <reference_text>Zaya MJ, Hines RN, Stevens JC: Epirubicin glucuronidation and UGT2B7 developmental expression.  Drug Metab Dispos. 2006 Dec;34(12):2097-101. Epub 2006 Sep 19.</reference_text>
        <pubmed_id>16985101</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>4'-Hydroxydiclofenac</name>
        <accession>HMDB13974</accession>
      </metabolite>
      <reference>
        <reference_text>Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.</reference_text>
        <pubmed_id>19515014</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>E-3179</name>
        <accession>HMDB13846</accession>
      </metabolite>
      <reference>
        <reference_text>Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.</reference_text>
        <pubmed_id>19515014</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Mycophenolate mofetil</name>
        <accession>HMDB14826</accession>
      </metabolite>
      <reference>
        <reference_text>Picard N, Ratanasavanh D, Premaud A, Le Meur Y, Marquet P: Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism. Drug Metab Dispos. 2005 Jan;33(1):139-46. Epub 2004 Oct 6.</reference_text>
        <pubmed_id>15470161</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Flurbiprofen</name>
        <accession>HMDB14850</accession>
      </metabolite>
      <reference>
        <reference_text>Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.</reference_text>
        <pubmed_id>19515014</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>O-Desmethylnaproxen</name>
        <accession>HMDB13989</accession>
      </metabolite>
      <reference>
        <reference_text>Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.</reference_text>
        <pubmed_id>19515014</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Suprofen</name>
        <accession>HMDB15008</accession>
      </metabolite>
      <reference>
        <reference_text>Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.</reference_text>
        <pubmed_id>19515014</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ezetimibe</name>
        <accession>HMDB15108</accession>
      </metabolite>
      <reference>
        <reference_text>Ghosal A, Hapangama N, Yuan Y, Achanfuo-Yeboah J, Iannucci R, Chowdhury S, Alton K, Patrick JE, Zbaida S: Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia). Drug Metab Dispos. 2004 Mar;32(3):314-20.</reference_text>
        <pubmed_id>14977865</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ezetimibe</name>
        <accession>HMDB15108</accession>
      </metabolite>
      <reference>
        <reference_text>Kosoglou T, Statkevich P, Johnson-Levonas AO, Paolini JF, Bergman AJ, Alton KB: Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet. 2005;44(5):467-94.</reference_text>
        <pubmed_id>15871634</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Mycophenolic acid</name>
        <accession>HMDB15159</accession>
      </metabolite>
      <reference>
        <reference_text>Dostalek M, Court MH, Hazarika S, Akhlaghi F: Diabetes mellitus reduces activity of human UDP-glucuronosyltransferase 2B7 in liver and kidney leading to decreased formation of mycophenolic acid acyl-glucuronide metabolite. Drug Metab Dispos. 2011 Mar;39(3):448-55. Epub 2010 Dec 1.</reference_text>
        <pubmed_id>21123165</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Mycophenolic acid</name>
        <accession>HMDB15159</accession>
      </metabolite>
      <reference>
        <reference_text>Picard N, Ratanasavanh D, Premaud A, Le Meur Y, Marquet P: Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism. Drug Metab Dispos. 2005 Jan;33(1):139-46. Epub 2004 Oct 6.</reference_text>
        <pubmed_id>15470161</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Mitiglinide</name>
        <accession>HMDB15382</accession>
      </metabolite>
      <reference>
        <reference_text>Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.</reference_text>
        <pubmed_id>19515014</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Flunitrazepam</name>
        <accession>HMDB15510</accession>
      </metabolite>
      <reference>
        <reference_text>Thomassin J, Tephly TR: Photoaffinity labeling of rat liver microsomal morphine UDP-glucuronosyltransferase by [3H]flunitrazepam. Mol Pharmacol. 1990 Sep;38(3):294-8.</reference_text>
        <pubmed_id>2119476</pubmed_id>
      </reference>
    </metabolite_reference>
  </metabolite_references>
</protein>
